1-6 of 6
cholecystitis, acute
Close
Sort by
Journal Articles

Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (iFCG) for First-Line Treatment of IGHV -Mutated CLL and without Del(17p)/Mutated TP53

Nitin Jain, MD, Philip A. Thompson, MBBS, Jan A. Burger, MD PhD, Alessandra Ferrajoli, MD, Koichi Takahashi, MD, Zeev E. Estrov, MD, Gautam M. Borthakur, MD, Prithviraj Bose, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Koji Sasaki, MD, Naveen Garg, MD, Xuemei Wang, MS, Rashmi Kanagal-Shamanna, MD, Keyur Patel, MD PhD, Jeffrey L. Jorgensen, MD PhD, Sa A Wang, MD, Wanda Lopez, RN, Ana Ayala, RN, William Plunkett, PhD, Varsha Gandhi, PhD, Hagop M. Kantarjian, MD, Susan O'Brien, MD, Michael J Keating, MBBS, William G. Wierda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 357.
https://doi.org/10.1182/blood-2019-131939
Published: 2019
Journal Articles

Safety of Addition of Inotuzumab Ozogamicin (CMC 544) to Bendamustine, Fludarabine, and Rituximab (BFR) Allogeneic Conditioning for Lymphoid Malignancies

Issa F. Khouri, Alison M. Gulbis, Denái R. Milton, Martin Korbling, MD, Celina Ledesma, Sairah Ahmed, Amin M. Alousi, MD, Betul Oran, MDMS, Paolo Anderlini, Stefan O. Ciurea, Roland L. Bassett, Jr., Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3240.
https://doi.org/10.1182/blood.V130.Suppl_1.3240.3240
Published: 2017
Journal Articles

Acute Cholecystitis Occurs More Commonly Than Expected Following Allogeneic Hematopoietic Stem Cell Transplantation and Is Ineffectively Diagnosed Using Abdominal Ultrasound

Stephen J. Bagley, MD, Alison R. Sehgal, MD, Noelle V. Frey, MD, Saar Gill, MD, PhD, Elizabeth Hexner, MD, Alison W. Loren, MD, James K. Mangan, MD, PhD, David L. Porter, MD, Ran Reshef, MD, Edward A. Stadtmauer, MD, Selina Luger, MD
Journal: Blood
Blood (2013) 122 (21): 2046.
https://doi.org/10.1182/blood.V122.21.2046.2046
Published: 2013
Journal Articles

Efficacy and Safety of Romiplostim in Patients with Low or Intermediate-Risk Myelodysplastic Syndrome (MDS) Receiving Decitabine.

Peter L Greenberg, MD, Guillermo Garcia-Manero, MD, Michael R Moore, MD, Lloyd E. Damon, MD, Gail J. Roboz, MD, Helen Wei, Hagop Kantarjian, MD, Janet L. Franklin, MD, MPH
Journal: Blood
Blood (2009) 114 (22): 1769.
https://doi.org/10.1182/blood.V114.22.1769.1769
Published: 2009
Journal Articles

Elective Cholecystectomy Decreases the Morbidity of Cholelithiasis and Cholecystectomy in Pediatric Sickle Cell Disease.

Emily F. Goodwin, MD, Paige M. Ivey, Jeffrey D. Lebensburger, DO, Roy P. McDonald, MPH, Thomas H. Howard, MD
Journal: Blood
Blood (2009) 114 (22): 1544.
https://doi.org/10.1182/blood.V114.22.1544.1544
Published: 2009
Journal Articles

Manual Erythro-Exchange (MEEX) to Prevent Complications of Sickle Cell Disease in Patients Unresponsive to Hydroxyurea: A Long-Term Follow-up

Gianluca Forni, MD, Manuela Balocco, Laura Terenzani, Paola Carrara
Journal: Blood
Blood (2008) 112 (11): 4815.
https://doi.org/10.1182/blood.V112.11.4815.4815
Published: 2008